A shopping feature published by USA TODAY says more women are adding collagen powder to their morning coffee after 40, choosing supplements that fit habits they already have rather than complicated multi-product routines. The piece is part of the outlet's Fall Reset, described as a curated shopping series highlighting products across beauty, wellness, personal care and other categories.

The product named is Alaya Naturals Multi Collagen Peptides, which the article says combines five collagen types with MSM, glucosamine and chondroitin in a single scoop. Collagen peptides are short chains of amino acids derived from animal collagen, and the article describes MSM, glucosamine and chondroitin as ingredients commonly found in joint and connective tissue support supplements.

What the article describes

The feature frames the appeal as convenience, saying collagen powders mix into coffee, smoothies and other beverages without adding steps to a busy schedule. It says shoppers often prefer products that integrate into existing routines without requiring significant lifestyle changes.

Who it is aimed at

According to the article, the formula is positioned for women over 40 looking for a single daily supplement designed to support skin, hair, nail, joint, bone and connective tissue health. That description carries the article's own asterisk noting the statements have not been evaluated by the Food and Drug Administration, and that the product is not intended to diagnose, treat, cure or prevent any disease.

Certification and stated drawbacks

The article says an unflavored option is NSF Contents Certified, which it presents as third-party ingredient verification for shoppers who prioritize ingredient transparency. It also lists considerations: a multi-source collagen formula may not be appropriate for people with fish or poultry allergies, and premium formulations may cost more than basic collagen peptide products.

What the piece does not include

No clinical trial, published study or outcome figure appears anywhere in the article, and no researcher or clinician is quoted. The comparisons it draws, such as a multi-collagen formula offering a broader collagen profile than single-source alternatives, are framed as points shoppers weigh rather than as tested results.

Outlook

The feature documents a consumer preference for simpler supplement routines and describes what one product contains, and its own disclaimer advises consulting a healthcare professional before starting any supplement regimen. Whether multi-collagen blends perform differently from single-source collagen peptides is not a question the article addresses.